Skip to main content
SpringerLink
Log in

Glycosaminoglycans and Neuroprotection

  • Chapter
  • First Online:
Heparin - A Century of Progress

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 207))

Abstract

Glycosaminoglycans (GAGs) are basic building blocks of the ground substance of the extracellular matrix and present at the cellular level as an important component of the glycocalyx covering the cell membrane. In addition to the general role of GAGs in maintaining the integrity of the cell and extracellular matrix by retaining water, certain GAGs exhibit anticoagulant and neuroprotective properties and serve as cell-surface receptors for various molecules. Although heparin, a highly sulfated GAG, has been used as a drug for more than 70 years due to its anticoagulant attributes, the neuroprotective properties of GAGs came into focus only in recent years. The discovery of some of the roles GAGs play in the pathomechanism of numerous neurodegenerative disorders as well as shedding light on the neuroprotective properties of these compounds in animal studies raised the possibility that GAGs may provide an entirely new avenue in the treatment of neurodegenerative diseases. Indeed, some GAGs were successfully used to improve the cognitive function of patients with various neurodegenerative conditions (Ban et al. (1991, 1992); Conti et al. (1989a, b); Passeri and Cucinotta, (1989); Santini (1989). Although the mechanism by which the GAGs exhibit neuroprotective properties is not entirely clear, there is a general consensus that the major factors of the neuroprotective attributes of GAGs include the impact of GAGs on amyloidogenesis and the regulatory action of GAGs in the apoptotic pathway.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Adjou KT, Simoneau S, Sales N et al (2003) A novel generation of heparan sulfate mimetics for the treatment of prion diseases. J Gen Virol 84:2595–2603

    PubMed  CAS  Google Scholar 

  • Alaniz L, Rizzo M, Malvicini M et al (2009) Low molecular weight hyaluronan inhibits colorectal carcinoma growth by decreasing tumor cell proliferation and stimulating immune response. Cancer Lett 278:9–16

    PubMed  CAS  Google Scholar 

  • Arrasate M, Perez M, Valpuesta JM et al (1997) Role of glycosaminoglycans in determining the helicity of paired helical filaments. Am J Pathol 151:1115–1122

    PubMed  CAS  Google Scholar 

  • Bae KH, Moon CW, Lee Y et al (2009) Intracellular delivery of heparin complexed with chitosan-g-poly(ethylene glycol) for inducing apoptosis. Pharm Res 26:93–100

    PubMed  CAS  Google Scholar 

  • Ban TA, Morey LC, Santini V (1991) Clinical investigations with ateroid in old-age dementias. Semin Thromb Hemost 17(Suppl 2):161–163

    PubMed  Google Scholar 

  • Ban TA, Morey LC, Fjetland OK et al (1992) Early manifestations of dementing illness: treatment with glycosaminoglycan polysulfate. Prog Neuropsychopharmacol Biol Psychiatry 16:661–676

    PubMed  CAS  Google Scholar 

  • Belmiro CL, Castelo-Branco MT, Melim LM et al (2009) Unfractionated heparin and new heparin analogues from ascidians (chordate-tunicate) ameliorate colitis in rats. J Biol Chem 284:11267–11278

    PubMed  CAS  Google Scholar 

  • Berry D, Lynn DM, Sasisekharan R et al (2004) Poly(beta-amino ester)s promote cellular uptake of heparin and cancer cell death. Chem Biol 11:487–498

    PubMed  CAS  Google Scholar 

  • Brezillon S, Venteo L, Ramont L et al (2007) Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma. Clin Exp Dermatol 32:405–416

    PubMed  CAS  Google Scholar 

  • Campo GM, Avenoso A, Campo S et al (2008a) Chondroitin-4-sulphate inhibits NF-kB translocation and caspase activation in collagen-induced arthritis in mice. Osteoarthritis Cartilage 16:1474–1483

    PubMed  CAS  Google Scholar 

  • Campo GM, Avenoso A, Campo S et al (2008b) NF-kB and caspases are involved in the hyaluronan and chondroitin-4-sulphate-exerted antioxidant effect in fibroblast cultures exposed to oxidative stress. J Appl Toxicol 28:509–517

    PubMed  CAS  Google Scholar 

  • Campo GM, Avenoso A, Campo S et al (2008c) The antioxidant effect exerted by TGF-1beta-stimulated hyaluronan production reduced NF-kB activation and apoptosis in human fibroblasts exposed to FeSo4 plus ascorbate. Mol Cell Biochem 311:167–177

    PubMed  CAS  Google Scholar 

  • Campo GM, Avenoso A, Campo S et al (2008d) Chondroitin-4-sulphate reduced oxidative injury in caerulein-induced pancreatitis in mice: the involvement of NF-kappaB translocation and apoptosis activation. Exp Biol Med (Maywood) 233:741–752

    CAS  Google Scholar 

  • Campo GM, Avenoso A, Campo S et al (2008e) The antioxidant activity of chondroitin-4-sulphate, in carbon tetrachloride-induced acute hepatitis in mice, involves NF-kappaB and caspase activation. Br J Pharmacol 155:945–956

    PubMed  CAS  Google Scholar 

  • Campo GM, Avenoso A, Campo S et al (2009) Glycosaminoglycans modulate inflammation and apoptosis in LPS-treated chondrocytes. J Cell Biochem 106:83–92

    PubMed  CAS  Google Scholar 

  • Castillo GM, Ngo C, Cummings J et al (1997) Perlecan binds to the beta-amyloid proteins (A beta) of Alzheimer’s disease, accelerates A beta fibril formation, and maintains A beta fibril stability. J Neurochem 69:2452–2465

    PubMed  CAS  Google Scholar 

  • Caughey B (1994) Scrapie-associated PrP accumulation and agent replication: effects of sulphated glycosaminoglycan analogues. Philos Trans R Soc Lond B Biol Sci 343:399–404

    PubMed  CAS  Google Scholar 

  • Caughey B, Race RE (1994) Scrapie-associated PrP accumulation and its inhibition: revisiting the amyloid-glycosaminoglycan connection. Ann N Y Acad Sci 724:290–295

    PubMed  CAS  Google Scholar 

  • Caughey B, Raymond GJ (1993) Sulfated polyanion inhibition of scrapie-associated PrP accumulation in cultured cells. J Virol 67:643–650

    PubMed  CAS  Google Scholar 

  • Caughey B, Brown K, Raymond GJ et al (1994) Binding of the protease-sensitive form of PrP (prion protein) to sulfated glycosaminoglycan and congo red [corrected]. J Virol 68:2135–2141

    PubMed  CAS  Google Scholar 

  • Chen X, Xiao W, Qu X et al (2008) The effect of dalteparin, a kind of low molecular weight heparin, on lung adenocarcinoma A549 cell line in vitro. Cancer Invest 26:718–724

    PubMed  CAS  Google Scholar 

  • Cohlberg JA, Li J, Uversky VN et al (2002) Heparin and other glycosaminoglycans stimulate the formation of amyloid fibrils from alpha-synuclein in vitro. Biochemistry 41:1502–1511

    PubMed  CAS  Google Scholar 

  • Conti L, Placidi GF, Cassano GB (1989a) Ateroid in the treatment of dementia: results of a clinical trial. Mod Probl Pharmacopsychiatry 23:76–84

    PubMed  CAS  Google Scholar 

  • Conti L, Re F, Lazzerini F et al (1989b) Glycosaminoglycan polysulfate (Ateroid) in old-age dementias: effects upon depressive symptomatology in geriatric patients. Prog Neuropsychopharmacol Biol Psychiatry 13:977–981

    PubMed  CAS  Google Scholar 

  • Deepa PR, Varalakshmi P (2006) Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 217:176–183

    PubMed  CAS  Google Scholar 

  • DeWitt DA, Silver J, Canning DR et al (1993) Chondroitin sulfate proteoglycans are associated with the lesions of Alzheimer’s disease. Exp Neurol 121:149–152

    PubMed  CAS  Google Scholar 

  • Diaz-Nido J, Wandosell F, Avila J (2002) Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases. Peptides 23:1323–1332

    PubMed  CAS  Google Scholar 

  • Dudas B (2009) Low molecular weight glycosaminoglycans and apoptosis: potential treatment of neurodegenerative disorders including Alzheimer’s Disease. Int J Med Biol Front 12:337–348

    Google Scholar 

  • Dudas B, Cornelli U, Lee JM et al (2002) Oral and subcutaneous administration of the glycosaminoglycan C3 attenuates Abeta(25–35)-induced abnormal tau protein immunoreactivity in rat brain. Neurobiol Aging 23:97–104

    PubMed  CAS  Google Scholar 

  • Dudas B, Rose M, Hanin I (2003) Dose-dependent effect of cholinotoxin AF64A on the cholinergic elements of the cingulum bundle in rat. Brain Res 965:295–298

    PubMed  CAS  Google Scholar 

  • Echigo R, Mochizuki M, Nishimura R et al (2006) Suppressive effect of hyaluronan on chondrocyte apoptosis in experimentally induced acute osteoarthritis in dogs. J Vet Med Sci 68:899–902

    PubMed  CAS  Google Scholar 

  • Erduran E, Tekelioglu Y, Gedik Y et al (1999) Apoptotic effects of heparin on lymphoblasts, neutrophils, and mononuclear cells: results of a preliminary in vitro study. Am J Hematol 61:90–93

    PubMed  CAS  Google Scholar 

  • Erduran E, Tekelioglu Y, Gedik Y et al (2004) In vitro determination of the apoptotic effect of heparin on lymphoblasts using DNA analysis and measurements of Fas and Bcl-2 proteins by flow cytometry. Pediatr Hematol Oncol 21:383–391

    PubMed  CAS  Google Scholar 

  • Erduran E, Deger O, Albayrak D et al (2007) In vitro investigation of the apoptotic effect of heparin on lymphoblasts by using flow cytometric DNA analysis and fluorometric caspase-3 and -8 activities. DNA Cell Biol 26:803–808

    PubMed  CAS  Google Scholar 

  • Fujii K, Fujii Y, Hubscher S et al (2001) CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells. J Immunol 167:1198–1203

    PubMed  CAS  Google Scholar 

  • Gabizon R, Meiner Z, Halimi M et al (1993) Heparin-like molecules bind differentially to prion-proteins and change their intracellular metabolic fate. J Cell Physiol 157:319–325

    PubMed  CAS  Google Scholar 

  • Ganguly BJ, Tonomura N, Benson RM et al (2002) Hyperbaric oxygen enhances apoptosis in hematopoietic cells. Apoptosis 7:499–510

    PubMed  CAS  Google Scholar 

  • Ghatak S, Misra S, Toole BP (2002) Hyaluronan oligosaccharides inhibit anchorage-independent growth of tumor cells by suppressing the phosphoinositide 3-kinase/Akt cell survival pathway. J Biol Chem 277:38013–38020

    PubMed  CAS  Google Scholar 

  • Goedert M, Jakes R, Spillantini MG et al (1996) Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans. Nature 383:550–553

    PubMed  CAS  Google Scholar 

  • Grishko V, Xu M, Ho R et al (2009) Effects of hyaluronic acid on mitochondrial function and mitochondria-driven apoptosis following oxidative stress in human chondrocytes. J Biol Chem 284:9132–9139

    PubMed  CAS  Google Scholar 

  • Guiroy DC, Yanagihara R, Gajdusek DC (1991) Localization of amyloidogenic proteins and sulfated glycosaminoglycans in nontransmissible and transmissible cerebral amyloidoses. Acta Neuropathol 82:87–92

    PubMed  CAS  Google Scholar 

  • Gupta-Bansal R, Frederickson RC, Brunden KR (1995) Proteoglycan-mediated inhibition of A beta proteolysis. A potential cause of senile plaque accumulation. J Biol Chem 270:18666–18671

    PubMed  CAS  Google Scholar 

  • Haider AS, Grabarek J, Eng B et al (2003) In vitro model of “wound healing” analyzed by laser scanning cytometry: accelerated healing of epithelial cell monolayers in the presence of hyaluronate. Cytometry A 53:1–8

    PubMed  Google Scholar 

  • Hasegawa M, Crowther RA, Jakes R et al (1997) Alzheimer-like changes in microtubule-associated protein Tau induced by sulfated glycosaminoglycans. Inhibition of microtubule binding, stimulation of phosphorylation, and filament assembly depend on the degree of sulfation. J Biol Chem 272:33118–33124

    PubMed  CAS  Google Scholar 

  • Hijazi N, Kariv-Inbal Z, Gasset M et al (2005) PrPSc incorporation to cells requires endogenous glycosaminoglycan expression. J Biol Chem 280:17057–17061

    PubMed  CAS  Google Scholar 

  • Hills FA, Abrahams VM, Gonzalez-Timon B et al (2006) Heparin prevents programmed cell death in human trophoblast. Mol Hum Reprod 12:237–243

    PubMed  CAS  Google Scholar 

  • Horonchik L, Tzaban S, Ben-Zaken O et al (2005) Heparan sulfate is a cellular receptor for purified infectious prions. J Biol Chem 280:17062–17067

    PubMed  CAS  Google Scholar 

  • Hosono K, Nishida Y, Knudson W et al (2007) Hyaluronan oligosaccharides inhibit tumorigenicity of osteosarcoma cell lines MG-63 and LM-8 in vitro and in vivo via perturbation of hyaluronan-rich pericellular matrix of the cells. Am J Pathol 171:274–286

    PubMed  CAS  Google Scholar 

  • Ishikawa Y, Kitamura M (1999) Inhibition of glomerular cell apoptosis by heparin. Kidney Int 56:954–963

    PubMed  CAS  Google Scholar 

  • Kaneko T, Saito H, Toya M et al (2000) Hyaluronic acid inhibits apoptosis in granulosa cells via CD44. J Assist Reprod Genet 17:162–167

    PubMed  CAS  Google Scholar 

  • Karti SS, Ovali E, Ozgur O et al (2003) Induction of apoptosis and inhibition of growth of human hepatoma HepG2 cells by heparin. Hepatogastroenterology 50:1864–1866

    PubMed  CAS  Google Scholar 

  • Kisilevsky R, Szarek WA (2002) Novel glycosaminoglycan precursors as anti-amyloid agents part II. J Mol Neurosci 19:45–50

    PubMed  CAS  Google Scholar 

  • Kisilevsky R, Lemieux LJ, Fraser PE et al (1995) Arresting amyloidosis in vivo using small-molecule anionic sulphonates or sulphates: implications for Alzheimer’s disease. Nat Med 1:143–148

    PubMed  CAS  Google Scholar 

  • Kisilevsky R, Szarek WA, Ancsin J et al (2003) Novel glycosaminoglycan precursors as anti-amyloid agents, part III. J Mol Neurosci 20:291–297

    PubMed  CAS  Google Scholar 

  • Kisilevsky R, Szarek WA, Ancsin J et al (2004) Novel glycosaminoglycan precursors as antiamyloid agents: part IV. J Mol Neurosci 24:167–172

    PubMed  CAS  Google Scholar 

  • Kisilevsky R, Ancsin JB, Szarek WA et al (2007) Heparan sulfate as a therapeutic target in amyloidogenesis: prospects and possible complications. Amyloid 14:21–32

    PubMed  CAS  Google Scholar 

  • Larramendy-Gozalo C, Barret A, Daudigeos E et al (2007) Comparison of CR36, a new heparan mimetic, and pentosan polysulfate in the treatment of prion diseases. J Gen Virol 88:1062–1067

    PubMed  CAS  Google Scholar 

  • Leveugle B, Scanameo A, Ding W et al (1994) Binding of heparan sulfate glycosaminoglycan to beta-amyloid peptide: inhibition by potentially therapeutic polysulfated compounds. Neuroreport 5:1389–1392

    PubMed  CAS  Google Scholar 

  • Li HL, Ye KH, Zhang HW et al (2001) Effect of heparin on apoptosis in human nasopharyngeal carcinoma CNE2 cells. Cell Res 11:311–315

    PubMed  CAS  Google Scholar 

  • Li HL, Ren XD, Zhang HW et al (2002) Synergism between heparin and adriamycin on cell proliferation and apoptosis in human nasopharyngeal carcinoma CNE2 cells. Acta Pharmacol Sin 23:167–172

    PubMed  CAS  Google Scholar 

  • Lisignoli G, Grassi F, Zini N et al (2001) Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) invovement. Arthritis Rheum 44:1800–1807

    PubMed  CAS  Google Scholar 

  • Liu IH, Uversky VN, Munishkina LA et al (2005) Agrin binds alpha-synuclein and modulates alpha-synuclein fibrillation. Glycobiology 15:1320–1331

    PubMed  CAS  Google Scholar 

  • Maeda S, Kimura H, Koga N et al (1993) Cell density-dependent DNA fragmentation and its suppression by heparin in primary culture of adult rat hepatocytes. Biochem Biophys Res Commun 195:270–275

    PubMed  CAS  Google Scholar 

  • Manaster J, Chezar J, Shurtz-Swirski R et al (1996) Heparin induces apoptosis in human peripheral blood neutrophils. Br J Haematol 94:48–52

    PubMed  CAS  Google Scholar 

  • Maneiro E, de Andres MC, Fernandez-Sueiro JL et al (2004) The biological action of hyaluronan on human osteoartritic articular chondrocytes: the importance of molecular weight. Clin Exp Rheumatol 22:307–312

    PubMed  CAS  Google Scholar 

  • Manero F, Ljubic-Thibal V, Moulin M et al (2004) Stimulation of Fas agonistic antibody-mediated apoptosis by heparin-like agents suppresses Hsp27 but not Bcl-2 protective activity. Cell Stress Chaperones 9:150–166

    PubMed  CAS  Google Scholar 

  • Mayer-Sonnenfeld T, Zeigler M, Halimi M et al (2005) The metabolism of glycosaminoglycans is impaired in prion diseases. Neurobiol Dis 20:738–743

    PubMed  CAS  Google Scholar 

  • Mayer-Sonnenfeld T, Avrahami D, Friedman-Levi Y et al (2008) Chemically induced accumulation of GAGs delays PrP(Sc) clearance but prolongs prion disease incubation time. Cell Mol Neurobiol 28:1005–1015

    PubMed  CAS  Google Scholar 

  • McBride PA, Wilson MI, Eikelenboom P et al (1998) Heparan sulfate proteoglycan is associated with amyloid plaques and neuroanatomically targeted PrP pathology throughout the incubation period of scrapie-infected mice. Exp Neurol 149:447–454

    PubMed  CAS  Google Scholar 

  • Ohashi R, Takahashi F, Cui R et al (2007) Interaction between CD44 and hyaluronate induces chemoresistance in non-small cell lung cancer cell. Cancer Lett 252:225–234

    PubMed  CAS  Google Scholar 

  • Pan T, Wong BS, Liu T et al (2002) Cell-surface prion protein interacts with glycosaminoglycans. Biochem J 368:81–90

    PubMed  CAS  Google Scholar 

  • Passeri M, Cucinotta D (1989) Ateroid in the clinical treatment of multi-infarct dementia. Mod Probl Pharmacopsychiatry 23:85–94

    PubMed  CAS  Google Scholar 

  • Pauloin T, Dutot M, Warnet JM et al (2008) In vitro modulation of preservative toxicity: high molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride. Eur J Pharm Sci 34:263–273

    PubMed  CAS  Google Scholar 

  • Pauloin T, Dutot M, Joly F et al (2009) High molecular weight hyaluronan decreases UVB-induced apoptosis and inflammation in human epithelial corneal cells. Mol Vis 15:577–583

    PubMed  CAS  Google Scholar 

  • Perez M, Valpuesta JM, Medina M et al (1996) Polymerization of tau into filaments in the presence of heparin:the minimal sequence required for tau–tau interaction. J Neurochem 67:1183–1190

    PubMed  CAS  Google Scholar 

  • Perez M, Wandosell F, Colaco C et al (1998) Sulphated glycosaminoglycans prevent the neurotoxicity of a human prion protein fragment. Biochem J 335(Pt 2):369–374

    PubMed  CAS  Google Scholar 

  • Perry G, Richey P, Siedlak SL et al (1992) Basic fibroblast growth factor binds to filamentous inclusions of neurodegenerative diseases. Brain Res 579:350–352

    PubMed  CAS  Google Scholar 

  • Pollack SJ, Sadler II, Hawtin SR et al (1995) Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells. Neurosci Lett 184:113–116

    PubMed  CAS  Google Scholar 

  • Priola SA, Caughey B (1994) Inhibition of scrapie-associated PrP accumulation. Probing the role of glycosaminoglycans in amyloidogenesis. Mol Neurobiol 8:113–120

    PubMed  CAS  Google Scholar 

  • Priola SA, Caughey B, Raymond GJ et al (1994) Prion protein and the scrapie agent: in vitro studies in infected neuroblastoma cells. Infect Agents Dis 3:54–58

    PubMed  CAS  Google Scholar 

  • Pumphrey CY, Theus AM, Li S et al (2002) Neoglycans, carbodiimide-modified glycosaminoglycans: a new class of anticancer agents that inhibit cancer cell proliferation and induce apoptosis. Cancer Res 62:3722–3728

    PubMed  CAS  Google Scholar 

  • Rose M, Dudas B, Cornelli U et al (2003) Protective effect of the heparin-derived oligosaccharide C3, on AF64A-induced cholinergic lesion in rats. Neurobiol Aging 24:481–490

    PubMed  CAS  Google Scholar 

  • Rose M, Dudas B, Cornelli U et al (2004) Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner. Brain Res 1015:96–102

    PubMed  CAS  Google Scholar 

  • Ruffell B, Johnson P (2008) Hyaluronan induces cell death in activated T cells through CD44. J Immunol 181:7044–7054

    PubMed  CAS  Google Scholar 

  • Sadler II, Hawtin SR, Tailor V et al (1995) Glycosaminoglycans and sulphated polyanions attenuate the neurotoxic effects of beta-amyloid. Biochem Soc Trans 23:106S

    PubMed  CAS  Google Scholar 

  • Santini V (1989) A general practice trial of Ateroid 200 in 8,776 patients with chronic senile cerebral insufficiency. Mod Probl Pharmacopsychiatry 23:95–100

    PubMed  CAS  Google Scholar 

  • Schonberger O, Horonchik L, Gabizon R et al (2003) Novel heparan mimetics potently inhibit the scrapie prion protein and its endocytosis. Biochem Biophys Res Commun 312:473–479

    PubMed  CAS  Google Scholar 

  • Schonherr E, O'Connell BC, Schittny J et al (1999) Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 78:44–55

    PubMed  CAS  Google Scholar 

  • Shaffer LM, Dority MD, Gupta-Bansal R et al (1995) Amyloid beta protein (A beta) removal by neuroglial cells in culture. Neurobiol Aging 16:737–745

    PubMed  CAS  Google Scholar 

  • Sheehan KM, DeLott LB, Day SM et al (2003) Hyalgan has a dose-dependent differential effect on macrophage proliferation and cell death. J Orthop Res 21:744–751

    PubMed  CAS  Google Scholar 

  • Sheehan KM, DeLott LB, West RA et al (2004) Hyaluronic acid of high molecular weight inhibits proliferation and induces cell death in U937 macrophage cells. Life Sci 75:3087–3102

    PubMed  CAS  Google Scholar 

  • Shimizu H, Sato S, Ohishi H et al (1997) Proteoglycans in senile dementia of Alzheimer’s type. Nippon Ronen Igakkai Zasshi 34:461–467

    PubMed  CAS  Google Scholar 

  • Shyng SL, Lehmann S, Moulder KL et al (1995) Sulfated glycans stimulate endocytosis of the cellular isoform of the prion protein, PrPC, in cultured cells. J Biol Chem 270:30221–30229

    PubMed  CAS  Google Scholar 

  • Simonaro CM, Haskins ME, Schuchman EH (2001) Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: a possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses. Lab Invest 81:1319–1328

    PubMed  CAS  Google Scholar 

  • Snow AD, Kinsella MG, Parks E et al (1995) Differential binding of vascular cell-derived proteoglycans (perlecan, biglycan, decorin, and versican) to the beta-amyloid protein of Alzheimer’s disease. Arch Biochem Biophys 320:84–95

    PubMed  CAS  Google Scholar 

  • Spillantini MG, Tolnay M, Love S et al (1999) Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathol 97:585–594

    PubMed  CAS  Google Scholar 

  • Takahashi K, Hashimoto S, Kubo T et al (2000) Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 27:1713–1720

    PubMed  CAS  Google Scholar 

  • Toole BP, Ghatak S, Misra S (2008) Hyaluronan oligosaccharides as a potential anticancer therapeutic. Curr Pharm Biotechnol 9:249–252

    PubMed  CAS  Google Scholar 

  • Tunjung WA, Yokoo M, Hoshino Y et al (2009) Effect of hyaluronan to inhibit caspase activation in porcine granulosa cells. Biochem Biophys Res Commun 382:160–164

    PubMed  CAS  Google Scholar 

  • Ueda K, Inoue S, Zhang Y et al (2009) Heparin induces apoptosis through suppression of AKt in oral squamous cell carcinoma cells. Anticancer Res 29:1079–1088

    PubMed  CAS  Google Scholar 

  • Uzun Y, Akdogan E, Ozdemir F et al (2009) The effects of heparin on DLD-1 colon cancer cell line. Bratisl Lek Listy 110:3–6

    PubMed  CAS  Google Scholar 

  • Van GD, David G, Lammens M et al (1993) Heparan sulfate expression patterns in the amyloid deposits of patients with Alzheimer’s and Lewy body type dementia. Dementia 4:308–314

    Google Scholar 

  • van HJ, de Vos RA, Steur EN et al (2004) Absence of heparan sulfate proteoglycans in Lewy bodies and Lewy neurites in Parkinson’s disease brains. J Alzheimers Dis 6:469–474

    Google Scholar 

  • Vana K, Zuber C, Nikles D et al (2007) Novel aspects of prions, their receptor molecules, and innovative approaches for TSE therapy. Cell Mol Neurobiol 27:107–128

    PubMed  CAS  Google Scholar 

  • Vij N, Roberts L, Joyce S et al (2004) Lumican suppresses cell proliferation and aids Fas-Fas ligand mediated apoptosis: implications in the cornea. Exp Eye Res 78:957–971

    PubMed  CAS  Google Scholar 

  • Vij N, Roberts L, Joyce S et al (2005) Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest Ophthalmol Vis Sci 46:88–95

    PubMed  Google Scholar 

  • Vincent T, Molina L, Espert L et al (2003) Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma. Br J Haematol 121:259–269

    PubMed  CAS  Google Scholar 

  • Vuillermoz B, Khoruzhenko A, D'Onofrio MF et al (2004) The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp Cell Res 296:294–306

    PubMed  CAS  Google Scholar 

  • Warner RG, Hundt C, Weiss S et al (2002) Identification of the heparan sulfate binding sites in the cellular prion protein. J Biol Chem 277:18421–18430

    PubMed  CAS  Google Scholar 

  • Wong C, Xiong LW, Horiuchi M et al (2001) Sulfated glycans and elevated temperature stimulate PrP(Sc)-dependent cell-free formation of protease-resistant prion protein. EMBO J 20:377–386

    PubMed  CAS  Google Scholar 

  • Wu Y, Wu J, Lee DY et al (2005) Versican protects cells from oxidative stress-induced apoptosis. Matrix Biol 24:3–13

    PubMed  CAS  Google Scholar 

  • Wu M, Bian Q, Liu Y et al (2009) Sustained oxidative stress inhibits NF-kappaB activation partially via inactivating the proteasome. Free Radic Biol Med 46:62–69

    PubMed  CAS  Google Scholar 

  • Yamin G, Munishkina LA, Karymov MA et al (2005) Forcing nonamyloidogenic beta-synuclein to fibrillate. Biochemistry 44:9096–9107

    PubMed  CAS  Google Scholar 

  • Yang T, Witham TF, Villa L et al (2002) Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas. Cancer Res 62:2583–2591

    PubMed  CAS  Google Scholar 

  • Yasuda M, Tanaka Y, Fujii K et al (2001) CD44 stimulation down-regulates Fas expression and Fas-mediated apoptosis of lung cancer cells. Int Immunol 13:1309–1319

    PubMed  CAS  Google Scholar 

  • Yasuda M, Nakano K, Yasumoto K et al (2002) CD44: functional relevance to inflammation and malignancy. Histol Histopathol 17:945–950

    PubMed  CAS  Google Scholar 

  • Yin S, Yu S, Li C et al (2006) Prion proteins with insertion mutations have altered N-terminal conformation and increased ligand binding activity and are more susceptible to oxidative attack. J Biol Chem 281:10698–10705

    PubMed  CAS  Google Scholar 

  • Yin S, Pham N, Yu S et al (2007) Human prion proteins with pathogenic mutations share common conformational changes resulting in enhanced binding to glycosaminoglycans. Proc Natl Acad Sci USA 104:7546–7551

    PubMed  CAS  Google Scholar 

  • Yu S, Yin S, Pham N et al (2008a) Ligand binding promotes prion protein aggregation – role of the octapeptide repeats. FEBS J 275:5564–5575

    PubMed  CAS  Google Scholar 

  • Yu TG, Zhang QZ, Zhang ZG et al (2008b) Protective effect of ultra low molecular weight heparin on glutamate-induced apoptosis in cortical cells. Yonsei Med J 49:486–495

    PubMed  CAS  Google Scholar 

  • Yue XL, Lehri S, Li P et al (2009) Insights on a new path of pre-mitochondrial apoptosis regulation by a glycosaminoglycan mimetic. Cell Death Differ 16:770–781

    PubMed  CAS  Google Scholar 

  • Zhou PH, Liu SQ, Peng H (2008) The effect of hyaluronic acid on IL-1beta-induced chondrocyte apoptosis in a rat model of osteoarthritis. J Orthop Res 26:1643–1648

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Neuroendocrine Organization Laboratory, Lake Erie College of Osteopathic Medicine, 1858 West Grandview Blvd, Erie, PA, 1509, USA

    B. Dudas

  2. Millcreek Community Hospital, 5515 Peach Street, Erie, PA, 16509, USA

    K. Semeniken

Authors
  1. B. Dudas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Semeniken
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to B. Dudas .

Editor information

Editors and Affiliations

  1. School of Pharmacy, University of London, Brunswick Square 29-39, London, WC1N 1AX, United Kingdom

    Rebecca Lever

  2. Standards and Control, National Institute for Biological, Blanche Lane, Potters Bar, Herts., EN6 3QG, United Kingdom

    Barbara Mulloy

  3. King's College London, Sackler Inst. Pulmonary Pharmacology, Waterloo Campus, London, SE1 9NH, United Kingdom

    Clive P. Page

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dudas, B., Semeniken, K. (2012). Glycosaminoglycans and Neuroprotection. In: Lever, R., Mulloy, B., Page, C. (eds) Heparin - A Century of Progress. Handbook of Experimental Pharmacology, vol 207. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-23056-1_14

Download citation

Publish with us

Policies and ethics

Search

Navigation